Alumis, Inc. (ALMS)
22.36
-0.85
(-3.66%)
USD |
NASDAQ |
Aug 28, 16:00
22.36
0.00 (0.00%)
After-Hours: 19:17
Alumis Cash from Operations (Quarterly) : -81.50M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -81.50M |
| March 31, 2026 | -87.08M |
| December 31, 2025 | -71.91M |
| September 30, 2025 | -110.91M |
| June 30, 2025 | -106.35M |
| March 31, 2025 | -80.36M |
| December 31, 2024 | -74.76M |
| Date | Value |
|---|---|
| September 30, 2024 | -83.77M |
| June 30, 2024 | -52.29M |
| March 31, 2024 | -44.26M |
| December 31, 2023 | -33.73M |
| September 30, 2023 | -33.25M |
| June 30, 2023 | -28.33M |
| March 31, 2023 | -34.67M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 33.54M |
| Aclaris Therapeutics, Inc. | -19.85M |
| Crinetics Pharmaceuticals, Inc. | -94.19M |
| Tarsus Pharmaceuticals, Inc. | 61.22M |
| Structure Therapeutics, Inc. | -120.38M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 68.69M |
| Cash from Financing (Quarterly) | 12.63M |
| Free Cash Flow | -351.80M |
| Free Cash Flow Per Share (Quarterly) | -0.6401 |
| Free Cash Flow to Equity (Quarterly) | -82.50M |
| Free Cash Flow to Firm (Quarterly) | -81.74M |
| Free Cash Flow Yield | -13.64% |